Felix's tips for Black Friday shopping
With Black Friday upon us, Science contributor Shrey Bohra writes about strategies to avoid getting ripped off
Charity CEOs plead for more support as research funding dwindles
Science writer Patrick Chan writes about the drought in medical science research funds caused by the pandemic
A conversation with Tom Whipple, Science editor of the Times
Science writer Allana Cullen attended the Felix Science event, A conversation with Tom Whipple
SpaceX Crew-1 successful launch and dock with ISS
The first ever privately operated space craft has docked with the ISS carrying 4 international astronauts
Moderna reveals 94.5% efficacy for its corona vaccine
Third major COVID vaccine candidate comes out of Phase III trials with an average efficacy of 94.5%
Are the UK government right to be investing in the new nuclear?
As the UK government continues to pump millions of pounds into the development of new nuclear facilities, Science Editor Lily Shepherd discusses whether this is really the right approach for the UK energy mix.
Rolls-Royce announces plans for 16 mini nuclear plants
Science editor Lily Shepard reports on the trend towards modular, smaller reactors that could rapidly boost nuclear power output
Felix Science Explained: How Does the Coronavirus Vaccine Work?
Ioana Esanu (writer) and Liyang Zhao (video producer) tackle a science question that's on everyone's mind at the moment.
Chinese Scientists Establish World's First Integrated Quantum Communication Network
Scientists at the University of Science and Technology of China have succeeded in integrating a huge quantum key distribution (QKD) network
“Felix Science Explained” Launching This Week
The Felix Science section launch their new series of pop science articles and videos, answering some of science's biggest questions
Free vitamin D to reduce COVID-19 risk
Vitamin D is being supplied to clinically vulnerable people in an attempt to protect them from COVID-19 symptoms
Coronavirus vaccine candidate shows 90% efficacy
Science Editor Julia Dabrowska reports on the results of the BioNTech/Pfizer vaccine trials, the first candidate vaccine in the fight against COVID-19